|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/54 | (2006.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61K 31/4152 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 4218732 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23166852.6 |
| Date of filing the European patent application | 2007-08-01 | |
| (97) | Date of publication of the European application | 2023-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-26 |
| (46) | Date of publication of the claims translation | 2025-06-25 |
| (30) | Number | Date | Country code |
| 915761 P | 2007-05-03 | US | |
| 947731 P | 2007-07-03 | US |
| (72) |
KAPSI, Shivakumar, G. , US
MULLER, Francis, X. , US
|
| (73) |
Novartis Pharma AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tabletės, apimančios eltrombopago olaminą |
| TABLETS COMPRISING ELTROMBOPAG OLAMINE |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 19 | 347.00 EUR |
| 2026-08-01 |